Home/Filings/4/0001181431-06-018663
4//SEC Filing

RENOVIS INC 4

Accession 0001181431-06-018663

CIK 0001118361operating

Filed

Mar 16, 7:00 PM ET

Accepted

Mar 17, 12:48 PM ET

Size

4.9 KB

Accession

0001181431-06-018663

Insider Transaction Report

Form 4
Period: 2006-03-16
KELLY MICHAEL GERALD
VP, Drug Discovery
Transactions
  • Sale

    Common Stock

    2006-03-16$23.38/sh4,000$93,52035,966 total
Footnotes (1)
  • [F1]Disposition of securities made pursuant to a 10b5-1 plan adopted by Dr. Kelly on March 17, 2005.

Issuer

RENOVIS INC

CIK 0001118361

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001118361

Filing Metadata

Form type
4
Filed
Mar 16, 7:00 PM ET
Accepted
Mar 17, 12:48 PM ET
Size
4.9 KB